breseq version 0.35.4 revision f352f80f4bc9
mutation predictions | marginal predictions | summary statistics | genome diff | command line log |
Marginal read alignment evidence | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
seq id | position | ref | new | freq | score (cons/poly) | reads | annotation | genes | product | ||
* | NZ_CP025268 | 1,293,000 | 0 | A | G | 63.4% | 142.3 / 282.6 | 274 | noncoding (37/132 nt) | CXP41_RS06835 | RtT sRNA |
* | NZ_CP025268 | 1,292,810 | 0 | G | A | 61.4% | 41.8 / inf | 386 | noncoding (49/132 nt) | CXP41_RS06830 | RtT sRNA |
* | NZ_CP025268 | 1,292,991 | 0 | C | T | 58.3% | 108.6 / 291.9 | 286 | noncoding (46/132 nt) | CXP41_RS06835 | RtT sRNA |
* | NZ_CP025268 | 1,292,982 | 0 | A | G | 48.6% | 80.2 / inf | 290 | noncoding (55/132 nt) | CXP41_RS06835 | RtT sRNA |
Marginal new junction evidence (lowest skew 10 of 335 shown) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
seq id | position | reads (cov) | reads (cov) | score | skew | freq | annotation | gene | product | ||
* | ? | NZ_CP025268 | 695911 = | 0 (0.000) | 171 (0.630) +GAAGAAACAATC |
38/252 | 3.2 | 54.9% | intergenic (‑33/+2) | CXP41_RS03680/CXP41_RS03685 | tRNA‑Gln/tRNA‑Gln |
? | NZ_CP025268 | = 696182 | 308 (1.040) | intergenic (‑1/+379) | CXP41_RS03695/asnB | tRNA‑Met/asparagine synthase B | |||||
* | ? | NZ_CP025268 | = 374376 | 353 (1.200) | 126 (0.430) | 37/276 | 3.8 | 26.7% | intergenic (+444/‑134) | dmpG/mhpT | 4‑hydroxy‑2‑oxovalerate aldolase/3‑(3‑hydroxy‑phenyl)propionate transporter |
? | NZ_CP025268 | = 376580 | 340 (1.150) | intergenic (+218/+6) | yaiL/fghA | DUF2058 domain‑containing protein/S‑formylglutathione hydrolase | |||||
* | ? | NZ_CP025268 | 4544596 = | 22 (0.070) | 59 (0.210) | 33/258 | 4.0 | 65.0% | intergenic (+49/‑433) | fimE/fimA | type 1 fimbria switch DNA invertase FimE/type 1 fimbrial major subunit FimA |
? | NZ_CP025268 | 4544910 = | 43 (0.160) | intergenic (+363/‑119) | fimE/fimA | type 1 fimbria switch DNA invertase FimE/type 1 fimbrial major subunit FimA | |||||
* | ? | NZ_CP025268 | = 3549238 | 417 (1.410) | 39 (0.150) +TTTTTTAATGATACGGCGAC |
26/236 | 4.7 | 10.2% | coding (1519/2085 nt) | malQ | 4‑alpha‑glucanotransferase |
? | NZ_CP025268 | 3549259 = | 384 (1.300) | coding (1498/2085 nt) | malQ | 4‑alpha‑glucanotransferase | |||||
* | ? | NZ_CP025268 | = 4544604 | 20 (0.070) | 24 (0.090) | 19/258 | 6.9 | 44.2% | intergenic (+57/‑425) | fimE/fimA | type 1 fimbria switch DNA invertase FimE/type 1 fimbrial major subunit FimA |
? | NZ_CP025268 | = 4544900 | 42 (0.150) | intergenic (+353/‑129) | fimE/fimA | type 1 fimbria switch DNA invertase FimE/type 1 fimbrial major subunit FimA | |||||
* | ? | NZ_CP025268 | 4411100 = | 433 (1.470) | 19 (0.070) | 12/246 | 8.8 | 5.0% | intergenic (+79/‑101) | rnr/rlmB | ribonuclease R/23S rRNA (guanosine(2251)‑2'‑O)‑methyltransferase RlmB |
? | NZ_CP025268 | 4411161 = | 344 (1.310) | intergenic (+140/‑40) | rnr/rlmB | ribonuclease R/23S rRNA (guanosine(2251)‑2'‑O)‑methyltransferase RlmB | |||||
* | ? | NZ_CP025268 | = 779967 | 351 (1.190) | 6 (0.030) +50 bp |
6/176 | 9.1 | 3.1% | noncoding (76/76 nt) | CXP41_RS04095 | tRNA‑Lys |
? | NZ_CP025268 | = 2525348 | 232 (0.790) | noncoding (61/76 nt) | CXP41_RS13270 | tRNA‑Lys | |||||
* | ? | NZ_CP025268 | = 779967 | 351 (1.190) | 6 (0.030) +50 bp |
6/176 | 9.1 | 3.0% | noncoding (76/76 nt) | CXP41_RS04095 | tRNA‑Lys |
? | NZ_CP025268 | = 780686 | 266 (0.900) | noncoding (61/76 nt) | CXP41_RS04115 | tRNA‑Lys | |||||
* | ? | NZ_CP025268 | = 779967 | 351 (1.190) | 6 (0.030) +50 bp |
6/176 | 9.1 | 2.7% | noncoding (76/76 nt) | CXP41_RS04095 | tRNA‑Lys |
? | NZ_CP025268 | = 780478 | 321 (1.090) | noncoding (61/76 nt) | CXP41_RS04110 | tRNA‑Lys | |||||
* | ? | NZ_CP025268 | = 779967 | 351 (1.190) | 6 (0.030) +50 bp |
6/176 | 9.1 | 2.6% | noncoding (76/76 nt) | CXP41_RS04095 | tRNA‑Lys |
? | NZ_CP025268 | = 780256 | 364 (1.230) | noncoding (61/76 nt) | CXP41_RS04105 | tRNA‑Lys |